David Silberstein

David Silberstein

Directeur/Bestuurslid bij LANTERN PHARMA INC.

Vermogen: - $ op 30-04-2024

73 jaar
Health Technology
Commercial Services
Consumer Services

Oorsprong van het eerstegraads netwerk van David Silberstein

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Major 14
3
Holding Company Pharmaceuticals: Major 3

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met David Silberstein via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Investment Managers

Marek Ciszewski

Analyst-Equity

Investment Managers

Leslie W. Kreis

Corporate Officer/Principal

APTOSE BIOSCIENCES INC. Pharmaceuticals: Major

Ernest Kitt

Chief Tech/Sci/R&D Officer

Information Technology Services

Panna Sharma

Director/Board Member

Investment Managers

Marek Ciszewski

Analyst-Equity

Pharmaceuticals: Major

David Margrave

Chief Administrative Officer

WHITESTONE REIT Real Estate Investment Trusts

Marek Ciszewski

Investor Relations Contact

ONCOSEC MEDICAL INCORPORATED Medical/Nursing Services

Ernest Kitt

Chief Tech/Sci/R&D Officer

IMMUNOME, INC. Biotechnology

Franklyn Prendergast

Director/Board Member

Miscellaneous Commercial Services

Franklyn Prendergast

Director/Board Member

Investment Managers

Marek Ciszewski

Analyst-Equity

Stanford University College/University

David Margrave

Undergraduate Degree

Illinois Institute of Technology College/University

Marek Ciszewski

Graduate Degree

Investment Managers

Marek Ciszewski

Corporate Officer/Principal

DePaul University College/University

Marek Ciszewski

Undergraduate Degree

Texas Christian University College/University

John Fucci

Leslie W. Kreis

Undergraduate Degree

Undergraduate Degree

The University of Texas at Austin College/University

David Margrave

Graduate Degree

University of Mumbai College/University

Kishor Bhatia

Doctorate Degree

Georgetown University College/University

Kishor Bhatia

Corporate Officer/Principal

Investment Trusts/Mutual Funds

Franklyn Prendergast

Kishor Bhatia

Corporate Officer/Principal

Corporate Officer/Principal

University of Pune College/University

Kishor Bhatia

Undergraduate Degree

University of Ibadan College/University

Reggie Ewesuedo

Doctorate Degree

Miscellaneous Commercial Services

David Margrave

Chairman

EPIRUS BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Marek Ciszewski

Investor Relations Contact

Pharmaceuticals: Major

Leslie W. Kreis

Director/Board Member

Investment Managers

Leslie W. Kreis

Corporate Officer/Principal

Mayo Medical School College/University

Franklyn Prendergast

Corporate Officer/Principal

Investment Managers

John Fucci

Leslie W. Kreis

Private Equity Analyst

Corporate Officer/Principal

Investment Managers

John Fucci

Leslie W. Kreis

Private Equity Investor

Founder

Investment Managers

Leslie W. Kreis

Founder

Financial Conglomerates

Leslie W. Kreis

Founder

Medical/Nursing Services

Franklyn Prendergast

Director/Board Member

ARAVIVE, INC. Biotechnology

Marek Ciszewski

Investor Relations Contact

Biotechnology

Peter L. Nara

Chief Tech/Sci/R&D Officer

NEUBASE THERAPEUTICS, INC. Pharmaceuticals: Major

Franklyn Prendergast

Director/Board Member

Pharmaceuticals: Major

Franklyn Prendergast

Director/Board Member

PERIMETER MEDICAL IMAGING AI, INC. Medical Specialties

Franklyn Prendergast

Director/Board Member

Biotechnology

Franklyn Prendergast

Director/Board Member

Investment Managers

Franklyn Prendergast

Consultant / Advisor

VYANT BIO, INC. Biotechnology

Franklyn Prendergast

Director/Board Member

Center For Individualized Medicine

Franklyn Prendergast

Director/Board Member

Ahmadu Bello University College/University

Reggie Ewesuedo

Graduate Degree

Statistieken

Internationaal

Verenigde Staten 40
Canada 5
India 3
Nigeria 3

Sectoraal

Finance 16
Health Technology 15
Consumer Services 12
Commercial Services 4
Health Services 3

Operationeel

Director/Board Member 51
Corporate Officer/Principal 37
Founder 17
Independent Dir/Board Member 13
Chief Executive Officer 12
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU